神经炎症在多发性硬化症模型中导致额头细胞功能障碍和嗅觉障碍
Charlotte Schubert1, Kristina Schulz2, Jana K Sonner1
1Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Journal of neuroinflammation
|March 8, 2025
概括
多发性硬化症 (MS) 的嗅觉功能障碍涉及到嗅觉球核神经元的损伤. 这项在多发性硬化动物模型 (EAE) 上的研究发现,神经炎症会影响额头细胞,通过改变通道活性来影响气味.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 眼科医生 眼科 眼科
背景情况:
- 嗅觉功能障碍是多发性硬化症 (MS) 的常见但未被认可的症状.
- 在MS中,炎症诱导的嗅球功能障碍的致病机制尚不清楚.
- 这项研究利用实验性自身免疫脑膜炎 (EAE) 模型,一种MS的动物模型,来研究这些机制.
研究的目的:
- 在MS的EAE模型中研究炎症诱导的嗅球功能障碍的致病机制.
- 为了确定特定的神经元群体和受神经炎症影响的分子通路在嗅觉灯泡中.
- 阐明在EAE期间的嗅觉功能障碍中中细胞的作用.
主要方法:
- 在相关动物模型中实验性自身免疫脑膜炎 (EAE) 诱导.
- 评估EAE动物的嗅觉功能.
- 嗅球细胞的单核RNA测序以分析基因表达变化.
- 确定分子标的功能验证,包括通道活性.
主要成果:
- 降低EAE的嗅觉功能与短轴神经元,不成熟神经元, mitra细胞和细胞的退化相关.
- 神经炎症诱导了 mitra 细胞中的通道转录的表达.
- 额头细胞中氨酸诱导的外向电流增加表明离子通道活性发生变化,导致嗅觉障碍.
结论:
- 密特拉细胞在EAE期间在嗅球中发挥着关键作用,EAE是MS的一个模型.
- 伴随神经炎症诱导的嗅觉功能障碍,中枢细胞中的通道活性发生变化.
- 这项研究增强了对影响嗅觉通路的MS中神经炎症驱动的神经退行症的理解.
关键词:
实验性的自身免疫性脑膜炎.mitra 细胞 mitra 细胞 是一种细胞.单原子离子通道活动单原子离子通道活动多发性硬化症是多发性硬化症.神经炎症是一种神经炎症.嗅觉灯泡是一种嗅觉灯泡.通道中的.单核RNA测序的一个核.任务二:完成第二个任务.更多相关视频
08:05Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017
9.2K
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
4.6K
相关概念视频
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
